Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

1.

Helical intravitreal triamcinolone acetonide implant: a 6-month surgical feasibility study in rabbits.

Mello-Filho PA, Guven D, Beeley NR, de Juan E Jr, Erickson SR.

Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr;40(2):160-8.

PMID:
19320305
[PubMed - indexed for MEDLINE]
2.

Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis.

Shin JP, Park YC, Oh JH, Lee JW, Kim YM, Lim JO, Kim SY.

J Ocul Pharmacol Ther. 2009 Jun;25(3):201-8. doi: 10.1089/jop.2008.0086.

PMID:
19456254
[PubMed - indexed for MEDLINE]
3.

Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.

Faghihi H, Taheri A, Farahvash MS, Esfahani MR, Rajabi MT.

Retina. 2008 Oct;28(9):1241-6. doi: 10.1097/IAE.0b013e31817d5be3.

PMID:
18626423
[PubMed - indexed for MEDLINE]
4.

Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.

Mruthyunjaya P, Khalatbari D, Yang P, Stinnett S, Tano R, Ashton P, Guo H, Nazzaro M, Jaffe GJ.

Arch Ophthalmol. 2006 Jul;124(7):1012-8.

PMID:
16832025
[PubMed - indexed for MEDLINE]
5.

A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.

Kim YM, Lim JO, Kim HK, Kim SY, Shin JP.

Eur J Pharm Biopharm. 2008 Sep;70(1):179-86. doi: 10.1016/j.ejpb.2008.04.023. Epub 2008 May 1.

PMID:
18667297
[PubMed - indexed for MEDLINE]
6.

Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.

Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P.

Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3569-75.

PMID:
11006254
[PubMed - indexed for MEDLINE]
Free Article
7.

Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

Berger AS, Cheng CK, Pearson PA, Ashton P, Crooks PA, Cynkowski T, Cynkowska G, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2318-25.

PMID:
8843916
[PubMed - indexed for MEDLINE]
Free Article
8.

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

Jaffe GJ, Yang CS, Wang XC, Cousins SW, Gallemore RP, Ashton P.

Ophthalmology. 1998 Jan;105(1):46-56.

PMID:
9442778
[PubMed - indexed for MEDLINE]
9.

Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.

McGee DH, Dembinska O, Gruebbel MM.

Int J Toxicol. 2005 Nov-Dec;24(6):419-25.

PMID:
16393934
[PubMed - indexed for MEDLINE]
10.

Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.

Kamppeter BA, Cej A, Jonas JB.

Ophthalmology. 2008 Aug;115(8):1372-5. doi: 10.1016/j.ophtha.2008.01.019. Epub 2008 Mar 20.

PMID:
18355920
[PubMed - indexed for MEDLINE]
11.

Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.

Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H.

Ophthalmic Surg Lasers. 2000 Nov-Dec;31(6):474-8.

PMID:
11095124
[PubMed - indexed for MEDLINE]
12.

Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.

Oliveira RC, Messias A, Siqueira RC, Bonini-Filho MA, Haddad A, Damico FM, Maia-Filho A, Crispim PT, Saliba JB, Ribeiro JA, Scott IU, Cunha-Jr AS, Jorge R.

Curr Eye Res. 2012 Jan;37(1):55-61. doi: 10.3109/02713683.2011.593722. Epub 2011 Oct 26.

PMID:
22029458
[PubMed - indexed for MEDLINE]
13.

Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.

Hosseini H, Mehryar M, Eghtedari M, Ahmadi F, Nowroozizadeh S.

Curr Eye Res. 2009 Feb;34(2):145-51. doi: 10.1080/02713680802585938.

PMID:
19219686
[PubMed - indexed for MEDLINE]
14.

Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.

Kai W, Yanrong J, Xiaoxin L.

Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1152-9. Epub 2006 Feb 2.

PMID:
16453123
[PubMed - indexed for MEDLINE]
15.

A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.

Robinson MR, Lee SS, Kim H, Kim S, Lutz RJ, Galban C, Bungay PM, Yuan P, Wang NS, Kim J, Csaky KG.

Exp Eye Res. 2006 Mar;82(3):479-87. Epub 2005 Sep 15.

PMID:
16168412
[PubMed - indexed for MEDLINE]
16.

Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A.

Gilger BC, Malok E, Stewart T, Ashton P, Smith T, Jaffe GJ, Allen JB.

Vet Ophthalmol. 2000;3(2-3):105-110.

PMID:
11397291
[PubMed - as supplied by publisher]
17.

Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.

Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1995 Feb;36(2):442-53.

PMID:
7843913
[PubMed - indexed for MEDLINE]
Free Article
18.

Vehicle used for triamcinolone acetonide is toxic to ocular tissues of the pigmented rabbit.

Zhengyu S, Fang W, Ying F.

Curr Eye Res. 2009 Sep;34(9):769-76.

PMID:
19839870
[PubMed - indexed for MEDLINE]
19.

Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.

Konstantinidis L, Berguiga M, Beknazar E, Wolfensberger TJ.

Retina. 2009 Sep;29(8):1119-27. doi: 10.1097/IAE.0b013e3181ac23da.

PMID:
19734764
[PubMed - indexed for MEDLINE]
20.

Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina.

Dierks D, Lei B, Zhang K, Hainsworth DP.

Arch Ophthalmol. 2005 Nov;123(11):1563-9.

PMID:
16286619
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk